May 9 Voyager Therapeutics Inc
* Voyager Therapeutics reports first quarter 2017 financial results and corporate highlights
* Q1 GAAP loss per share $0.65
* Q1 earnings per share view $-0.53 -- Thomson Reuters I/B/E/S
* Voyager Therapeutics Inc - Collaboration revenues of $1.5 million for Q1 of 2017 compared to collaboration revenues of $4.8 million for Q1 of 2016. Source text for Eikon: Further company coverage:
Itaú's Setubal sees high growth at Brazil's XP
SAO PAULO, June 24 The price that Itaú Unibanco Holding SA paid for a minority stake in Brazilian independent securities firm XP Investimentos SA embeds "very high growth rates" ahead, co-Chairman Roberto Setubal said on Saturday.